Research Management and Impact Tool (ReMIT)

Suzette

Epicentre

Studies

Status: Completion

Miltefosine for treatment of cutaneous leishmaniasis caused by Leishmania tropica in Quetta, Pakistan

Study details: Observational study in Pakistan

Principal investigator: Suzette

Latest update: 2nd August 2022

Status: Implementation

Randomised, open label, multicentre clinical non-inferiority trial for new treatment modalities for cutaneous leishmaniasis caused by Leishmania tropica in Pakistan

Study details: Randomised controlled trial (RCT) in Pakistan

Principal investigator: Suzette

Latest update: Document added | 20th September 2023

Status: Implementation

Cutaneous leishmaniasis patient characteristics and treatment outcomes, Quetta Pakistan 2014-2020

Study details: Observational study in Pakistan

Principal investigator: Suzette

Latest update: Implementation update added | 31st August 2023